SCHEMBL20042356

SCHEMBL20042356

CCOC(=O)C(C)(C)CC(C)(C)Oc1cc(Nc2nc(C)nc3ccccc23)ccc1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 9/20 0.48
ABCG2 Q9UNQ0 9/20 0.48
ABCC1 P33527 6/20 0.48
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
TP53 P04637 3/20 0.46
SHMT2 P34897 1/20 0.45
MAPT P10636 7/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
GAA P10253 3/20 0.45
NPSR1 Q6W5P4 2/20 0.45
NPY1R P25929 1/20 0.45
NPY2R P49146 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
GPR55 Q9Y2T6 1/20 0.45
KDM4E B2RXH2 3/20 0.45
L3MBTL1 Q9Y468 2/20 0.44
ALDH1A1 P00352 2/20 0.44
HPGD P15428 2/20 0.44
POLB P06746 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20042056 0.80 ABCG2 (0.53) ABCB1ABCG2ABCC1MEN1KMT2A
SCHEMBL29126705 0.80 ABCG2 (0.53) ABCB1ABCG2ABCC1MEN1KMT2A
SCHEMBL2256504 0.78 ABCG2 (0.73) ABCB1ABCG2ABCC1MEN1KMT2A
SCHEMBL18088137 0.78 DHFR (0.55) ABCB1ABCG2ABCC1MEN1KMT2A
SCHEMBL31150159 0.75 ABCG2 (0.54) ABCB1ABCG2ABCC1
SCHEMBL29126710 0.73 ABCG2 (0.61) ABCB1ABCG2ABCC1MEN1KMT2A
SCHEMBL20042294 0.73 MAPT (0.43) MEN1KMT2AMAPTGAAKDM4E
SCHEMBL3109746 0.71 ABCG2 (0.74) ABCB1ABCG2ABCC1MEN1KMT2A
SCHEMBL29126698 0.71 CYP1A2 (0.66) ABCB1ABCG2ABCC1MEN1KMT2A
SCHEMBL2256420 0.70 POLB (0.67) ABCB1ABCG2ABCC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180098990-A1 HISTONE DEACETYLASE INHIBITOR, AND PREPARATION METHOD AND USE THEREOF GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD (CN) 2018-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180098990-A1 HISTONE DEACETYLASE INHIBITOR, AND PREPARATION METHOD AND USE THEREOF HDAC1, HDAC5, HDAC9 ABCB1 1390/4885ABCG2 198/4885ABCC1 2038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.